Popular Trials
Verdiperstat for Frontotemporal Dementia
This trial tests the safety of Verdiperstat, a medication taken regularly, in patients with language difficulties caused by brain issues. The study aims to see if the drug can change protein levels in the brain and improve cognitive functions.
Behavioral Intervention
Pain Sensitivity Study for Child Development
"This trial aims to understand how childhood experiences of adversity can affect pain sensitivity and mental health later in life. Children in the study will be asked to put their hand in cold water to see how they react
Antioxidant
MitoQ for Peripheral Arterial Disease
This trial aims to investigate if taking MitoQ for six months can help improve the symptoms and function of people with peripheral artery disease, specifically those experiencing leg pain while walking. We will be looking at
Popular Filters
Trials With No Placebo
MRI Technique
Abbreviated Biparametric MRI for Prostate Cancer
This trial is testing a new MRI scan method for men with newly diagnosed prostate cancer. The scan combines detailed imaging and water movement analysis to detect cancer. The goal is to see if this method is as effective as the standard MRI but simpler and cheaper.
Neuroinflammation Imaging for Alzheimer's Disease
This trial uses a special brain scan with a new substance to highlight brain inflammation. It targets people with Alzheimer's Disease and those with brain issues. The scan helps doctors see inflammation in the brain.
Imaging Agent
FAPi PET/CT Imaging for Prostate Cancer
This trial is testing a new imaging technique to see if it can detect prostate cancer. The technique uses a tracer called 68Ga-FAPi-46 which is taken up by some cancer cells. If successful, this technique could provide additional information about various types of cancer in the future.
View More Related Trials
Frequently Asked Questions
Introduction to pathology
What are the top hospitals conducting pathology research?
In the realm of pathology, hospitals dedicated to unraveling the mysteries of diseases and improving patient outcomes take center stage. Among them is The University of Alabama at Birmingham in Birmingham, where innovative research is currently underway with two active pathology trials. While they may not have a history of previous studies in this field, their commitment to advancing knowledge and understanding cannot be overlooked. Similarly, UCLA's Jonsson Comprehensive Cancer Center in Los Angeles has also prioritized pathology research with two ongoing clinical trials focused on this crucial area. It is worth noting that these institutions are making significant strides despite not having conducted any past pathology trials.
Another prominent hospital contributing to the field is Henry Ford Health in Royal Oak. Although they currently have one active trial exploring aspects of pathology, their dedication to pushing boundaries warrants recognition. Meanwhile, across the country at UCSF Memory and Aging Center in San Francisco, researchers are actively engaged in one groundbreaking pathology trial aimed at shedding light on complex diseases affecting memory and cognition.
Lastly but by no means least important,Beth Israel Deaconess Medical Center located amidst Boston's vibrant medical community has been tirelessly working towards better understanding through its single active trial dedicated entirely to studying various facets within Pathology domain.Though it lacks historical data for referring back yet it remains undeterred showcasing sheer devotion prevailing among experts committed towards enhancing healthcare standards
These esteemed hospitals display unwavering commitment when it comes to investigating pathological conditions that affect countless individuals worldwide. Their collective efforts underscore the importance of cutting-edge research as we strive towards new breakthroughs essential for improving diagnostic accuracy and treatment strategies for patients everywhere
Which are the best cities for pathology clinical trials?
When it comes to pathology clinical trials, a few cities stand out as leaders in research and development. Chicago, Illinois tops the list with 3 active trials focusing on diverse areas such as body weight walking, hip arthroscopy, and imaging techniques like [18F]NAV4694. Royal Oak, Michigan follows closely behind with 2 ongoing studies exploring treatment options and surgical interventions like PAO with hip arthroscopy. Lastly, Birmingham in Alabama offers 2 active trials investigating innovative PET scans like [11C]PiB and 18F-labeled DPA-714. These cities provide individuals interested in pathology clinical trials access to cutting-edge research that pushes the boundaries of diagnostic methods and treatments.
Which are the top treatments for pathology being explored in clinical trials?
In the realm of clinical trials, several top treatments are currently being explored for pathology. These include:
- Daratumumab: Engaged in six active trials and 134 all-time breast cancer trials since its introduction in 2012.
- Belantamab mafodotin: Under scrutiny with four ongoing trials and a total of 26 breast cancer trials to date, starting from 2018.
- Lenalidomide: Being investigated in three active breast cancer studies alongside an impressive history of 280 clinical trials since its inception in 2003.
These innovative treatments offer hope for advancing the field of pathology and improving outcomes for patients worldwide.
What are the most recent clinical trials for pathology?
Exciting advancements are being made in the field of pathology, as recent clinical trials offer new possibilities for diagnosis and treatment. One such trial explores a virtual group speech therapy intervention program, guided by a patient partner. By leveraging technology, patients can benefit from personalized therapy sessions that address their specific needs. Additionally, verdiperstat shows promise as a potential treatment option for pathology patients. This compound is currently undergoing Phase 1 testing to evaluate its safety and efficacy. The research also includes studies focused on Down syndrome-related pathology and the use of C-11 ER176 PET/CT imaging to aid in diagnosis. These groundbreaking trials signify significant progress in understanding and managing various pathologies, bringing hope to both patients and medical professionals alike.
What pathology clinical trials were recently completed?
Several recent clinical trials in the field of pathology have successfully concluded, signifying significant advancements in diagnosing and understanding diseases. Notably, a trial focusing on Uproleselan sponsored by Washington University School of Medicine was completed in October 2021. Additionally, the National Cancer Institute wrapped up a trial investigating mRNA-1273 therapy in September 2021. Another noteworthy completion occurred with AgenTus Therapeutics' agenT-797 study back in January 2021. These trials highlight the dedication and progress made by researchers seeking to improve pathological diagnosis and treatment options for patients.